person

Gwenola K.

Country
France
Department
Assistance Médicale à la Procréation

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 8 partner sites.

Specializations

Assisted Reproductive Medicine

Focus on optimizing embryo development and implantation through advanced laboratory techniques such as in vitro fertilization and intracytoplasmic sperm injection.

  • IVF
  • ICSI
  • embryo transfer
  • pre‑implantation culture
  • oocyte incubation

Clinical work is conducted at the Groupe Hospitalier Diaconesses Croix Saint Simon in Paris.

Gynecologic Oncology

Investigation of molecularly driven therapies for gynecologic cancers including endometrial, ovarian, and cervical malignancies.

  • Endometrial cancer
  • High‑grade serous ovarian cancer
  • Cervical carcinoma
  • FGFR2b‑targeted agents
  • PARP inhibitor resistance

Emphasis on biomarker‑guided treatment strategies across multiple tumor sites.

Prostate Cancer and Male Reproductive Oncology

Research on advanced prostate adenocarcinoma and associated hormonal treatment strategies.

  • Castration‑resistant prostate cancer
  • Prostatic adenocarcinoma with high recurrence risk
  • Hormone therapy resistance
  • Molecular profiling in male cancers
  • FGFR2b expression in male malignancies

Integration of systemic and local therapeutic approaches for male reproductive tumors.

Cancer‑Associated Thrombosis

Evaluation of cancer‑associated thrombosis and anticoagulation management in oncologic populations.

  • Venous thromboembolism
  • Anticoagulant strategies
  • Thrombotic biomarkers
  • Risk assessment models
  • Thrombosis prevention in solid tumors

Collaborative research bridges oncology and hematology disciplines.

Immunotherapy and Targeted Molecular Therapy

Development of immune checkpoint inhibition and targeted drug combinations across solid tumors.

  • PD‑1/PD‑L1 blockade
  • HER2‑targeted therapy
  • FGFR inhibitors
  • PARP inhibitors
  • Antibody‑drug conjugates

Multi‑tumor platform trials leverage molecular profiling to guide treatment selection.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.